What does Astrazeneca Phar do?
AstraZeneca Pharma India Limited manufactures, distributes, and markets pharmaceutical products, reporting net sales of ₹4,805 Cr and a net profit of ₹582 Cr for the quarter ending March 2025. It has a market cap of ₹23,391 Cr and key metrics include a P/E ratio of 114.00 and a return on equity of 28.39%.
Overview: AstraZeneca Pharma India Limited is engaged in the manufacture, distribution, and marketing of pharmaceutical products within the Pharmaceuticals & Biotechnology industry and is categorized as a Large Cap company.History:
AstraZeneca Pharma India Ltd was incorporated on July 11, 1979. The latest quarterly results reported net sales and net profit for the period ending March 2025.
Financial Snapshot:
Net Sales: 4,805 Cr (Quarterly Results - Mar 2025)
Net Profit: 582 Cr (Quarterly Results - Mar 2025)
Market Cap: INR 23,391 Cr (Large Cap)
Key Metrics:
P/E: 114.00
Industry P/E: 37
Dividend Yield: 0.00%
Debt-Equity: -0.70
Return on Equity: 28.39%
Price to Book: 32.23
Contact Details:
Address: Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road Bangalore Karnataka : 560045
Tel: 91-080-67748000
Email: comp.secy@astrazeneca.com
Website: http://www.astrazeneca.in
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
